CLINICAL_TRIALS
trial_result
· 2026-03-13
Clinical Trial Update: Imatinib in Adult Patients With Metastatic Ocular Melanoma [Phase 2]
Summary
A Phase 2 trial of imatinib in adults with metastatic ocular melanoma has been terminated.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Centre Oscar Lambret | Conditions: Melanoma | Phase 2 | Status: TERMINATED